BR112012013041A2 - biomarcador específico para melanoma - Google Patents
biomarcador específico para melanomaInfo
- Publication number
- BR112012013041A2 BR112012013041A2 BR112012013041A BR112012013041A BR112012013041A2 BR 112012013041 A2 BR112012013041 A2 BR 112012013041A2 BR 112012013041 A BR112012013041 A BR 112012013041A BR 112012013041 A BR112012013041 A BR 112012013041A BR 112012013041 A2 BR112012013041 A2 BR 112012013041A2
- Authority
- BR
- Brazil
- Prior art keywords
- melanoma
- specific biomarker
- acid sequence
- specific
- biomarkers
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title abstract 4
- 201000001441 melanoma Diseases 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 108700005856 engrailed 2 Proteins 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 238000012800 visualization Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0921329.9A GB0921329D0 (en) | 2009-12-04 | 2009-12-04 | Biomarker |
| PCT/GB2010/001334 WO2011067549A1 (en) | 2009-12-04 | 2010-07-13 | Melanoma specific biomarker |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012013041A2 true BR112012013041A2 (pt) | 2016-10-11 |
Family
ID=41641989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012013041A BR112012013041A2 (pt) | 2009-12-04 | 2010-07-13 | biomarcador específico para melanoma |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20120263654A1 (enExample) |
| EP (1) | EP2507384A1 (enExample) |
| JP (1) | JP2013512668A (enExample) |
| CN (1) | CN102791878A (enExample) |
| AU (1) | AU2010326433A1 (enExample) |
| BR (1) | BR112012013041A2 (enExample) |
| CA (1) | CA2782034A1 (enExample) |
| GB (1) | GB0921329D0 (enExample) |
| IL (1) | IL219834A0 (enExample) |
| IN (1) | IN2012DN04381A (enExample) |
| MX (1) | MX2012006229A (enExample) |
| RU (1) | RU2012121096A (enExample) |
| WO (1) | WO2011067549A1 (enExample) |
| ZA (1) | ZA201203517B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2626437A3 (en) | 2008-05-14 | 2013-12-11 | Dermtech International | Diagnosis of melanoma and solar lentigo by nucleic acid analysis |
| US20150005184A1 (en) * | 2013-06-28 | 2015-01-01 | Dermtech International | Diagnosis of melanoma by nucleic acid analysis |
| WO2016168174A1 (en) * | 2015-04-13 | 2016-10-20 | The Translational Genomics Research Institute | Predicting the occurrence of metastatic cancer using epigenomic biomarkers and non-invasive methodologies |
| MY194686A (en) * | 2015-06-24 | 2022-12-15 | Oxford BioDynamics PLC | Detection of chromosome interactions |
| KR101777085B1 (ko) * | 2017-02-23 | 2017-09-11 | 주식회사 성균바이오텍 | En2 단백질의 면역원성 단편 펩타이드 또는 이를 특이적으로 인식하는 항체 조성물 |
| EP3752645A4 (en) | 2018-02-14 | 2022-04-13 | Dermtech, Inc. | Novel gene classifiers and uses thereof in non-melanoma skin cancers |
| JP2022524641A (ja) | 2019-03-26 | 2022-05-09 | ダームテック，インク． | 皮膚癌における新規な遺伝子分類子とその使用 |
| RU2766739C1 (ru) * | 2021-04-12 | 2022-03-15 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Блохина" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Блохина" Минздрава России) | Способ прогноза эффективности терапии меланомы |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2469089A1 (en) * | 2003-07-08 | 2005-01-08 | Institut De Recherches Cliniques De Montreal | En-2 gene, disgnostic and therapeutic uses thereof |
| US20070154889A1 (en) * | 2004-06-25 | 2007-07-05 | Veridex, Llc | Methods and reagents for the detection of melanoma |
| US7615349B2 (en) * | 2006-09-07 | 2009-11-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Melanoma gene signature |
| US7960110B2 (en) * | 2006-11-15 | 2011-06-14 | The Regents Of The University Of California | Detection of chromosomal region copy number changes to diagnose melanoma |
| GB0625321D0 (en) * | 2006-12-19 | 2007-01-24 | Univ Surrey | Cancer biomarker |
| WO2009131733A1 (en) * | 2008-04-21 | 2009-10-29 | The Trustees Of Columbia University In The City Of New York | Gab2 amplification in melanoma |
-
2009
- 2009-12-04 GB GBGB0921329.9A patent/GB0921329D0/en not_active Ceased
-
2010
- 2010-07-13 JP JP2012541569A patent/JP2013512668A/ja active Pending
- 2010-07-13 BR BR112012013041A patent/BR112012013041A2/pt not_active IP Right Cessation
- 2010-07-13 WO PCT/GB2010/001334 patent/WO2011067549A1/en not_active Ceased
- 2010-07-13 RU RU2012121096/10A patent/RU2012121096A/ru not_active Application Discontinuation
- 2010-07-13 MX MX2012006229A patent/MX2012006229A/es not_active Application Discontinuation
- 2010-07-13 CA CA2782034A patent/CA2782034A1/en not_active Abandoned
- 2010-07-13 IN IN4381DEN2012 patent/IN2012DN04381A/en unknown
- 2010-07-13 US US13/513,345 patent/US20120263654A1/en not_active Abandoned
- 2010-07-13 AU AU2010326433A patent/AU2010326433A1/en not_active Abandoned
- 2010-07-13 EP EP10742865A patent/EP2507384A1/en not_active Withdrawn
- 2010-07-13 CN CN2010800550196A patent/CN102791878A/zh active Pending
-
2012
- 2012-05-15 ZA ZA2012/03517A patent/ZA201203517B/en unknown
- 2012-05-16 IL IL219834A patent/IL219834A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011067549A1 (en) | 2011-06-09 |
| IN2012DN04381A (enExample) | 2015-08-07 |
| MX2012006229A (es) | 2012-06-19 |
| JP2013512668A (ja) | 2013-04-18 |
| IL219834A0 (en) | 2012-07-31 |
| ZA201203517B (en) | 2013-02-27 |
| CA2782034A1 (en) | 2011-06-09 |
| CN102791878A (zh) | 2012-11-21 |
| RU2012121096A (ru) | 2014-01-10 |
| US20120263654A1 (en) | 2012-10-18 |
| GB0921329D0 (en) | 2010-01-20 |
| EP2507384A1 (en) | 2012-10-10 |
| AU2010326433A1 (en) | 2012-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012013041A2 (pt) | biomarcador específico para melanoma | |
| WO2014145820A3 (en) | Multiple tagging of long dna fragments | |
| HK1211260A1 (en) | Method and kit for nucleic acid sequencing | |
| AU2010315303A8 (en) | Quantitative Nuclease Protection Sequencing (qNPS) | |
| EP2351575A4 (en) | NEW USE OF GRS PROTEINS OR FRAGMENTS THEREOF | |
| WO2016065349A3 (en) | Short non-coding protein regulatory rnas (sprrnas) and methods of use | |
| BRPI0807132A2 (pt) | enzimas para o tratamento de lignocelulósicos, ácidos nucléicos que codificam as mesmas, e metodos e uso das mesmas | |
| HK1223659A1 (zh) | 基於可多重标签的报告系统 | |
| BR112012008054A2 (pt) | domínios catalíticos de lisil oxidase e loxl2 | |
| AR070717A1 (es) | Lipasas y usos de las mismas en la industria lactea | |
| EA201491159A1 (ru) | Способы и композиции для анализа ahasl генов в пшенице | |
| ATE515488T1 (de) | Click-chemie zur herstellung von reportermolekülen | |
| WO2013181256A3 (en) | Novel pharmacogene single nucleotide polymorphisms and methods of detecting same | |
| BR112014021993B8 (pt) | "métodos para detecção de uma variação de nucleotídeo em uma sequência de ácido nucleico alvo através de um ensaio de ptoce" | |
| BR112012011576A2 (pt) | dna de minicírculos superenrolados para aplicações de terapia genética | |
| WO2019094780A3 (en) | Non-coding rna for detection of cancer | |
| BR112014003877A2 (pt) | biomarcadores de micro-rna e métodos de uso dos mesmos | |
| WO2012061502A3 (en) | Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof | |
| BR112017025995A2 (pt) | inibidor de igfbp3, composição farmacêutica para uso no tratamento e/ou prevenção de um distúrbio intestinal, método para o diagnóstico de um distúrbio intestinal em um indivíduo e kit para o diagnóstico de um distúrbio intestinal | |
| BRPI0906090A2 (pt) | substrato para análise de uma enzima, molécula e método para detectar atividade enzimática . | |
| MX2011006773A (es) | Biomarcador. | |
| BR112013001863A2 (pt) | peptídeos com efeitos analgésicos e inibindo os canais asic. | |
| BR112014011937A2 (pt) | detecção altamente multiplexada quantitativa de ácidos nucléicos | |
| BR112017028035A2 (pt) | aminopeptidases para hidrolisados de proteína | |
| BRPI1007979A2 (pt) | Anticorpos anti-mst1r e usos dos mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |